1[1]Testino G, Cornaggia M, De Iaco F. Helicobacter pylori influence on gastric acid secretion in duodenal ulcer patients diagnosed for the first time [J]. Panminerva Med, 2002,44 ( 1 ): 19-22.
3[3]Graham DY, Lew GM, Lechago J, et al. Antral G-cell and D-cell numbers in Helicobacter pylori infection:effect of H.pylori eradication[J].Gastroenterol, 1993,10(3) :324-328.
4[5]Kim JH, Park HJ, Cho JS. Relationship of CagA to serum gastrin concentrations and antral G, D cell densities in Helicobecter pylori infection[J] .Yonsei Med J, 1999,40(4) :301-306.
5[6]Chittajallu RS, Nrithercut WD, Macdonald AM, et al. Effect of increasing Helicobacter pylori ammonia production byurea infusion on plasma gastrin concentrions[ J]. Gut, 1991,32( 1 ): 21-24.
6[7]Konturek JW, Bielanski W, Konturek SJ. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients [J].Physiol Pharmacol, 1996,47( 1 ): 161-175.
7[8]Suzuki T, Grand E, Bowman C. TNF-alpha and interleukin 1 activate gastrin gene expression via MAPK- and PKC-dependent mechanisms[J]. Am J Physiol Gastrointest Liver Physiol, 2001,281 (6): G1405-1412.
8[9]Leve S, Beardshal LK, Heddad G, et al. Camp Helicobacter pylori and duodenal ulcers: the gastrin link[ J]. Lancet, 1989,11 (7): 1167.
9[10]Yamashita Y, Inoue H, Ohta K, et al. Manometricand hormonal changes after distal partial gastrectomy [ J ]. Aliment Pharmacol Ther, 2000, 14( 1 ): 166-169.
2El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998,43:327-333.
3Pera M,Cameron AJ,Trastek VF,et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology, 1993,104:510-513.
4Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett′s esophagus, Barrett′s dysplasia, and Barrett′s adenocarcinoma. Am J Gastroenterol,2000,95:387-394.
5Schenk BE, Kuipers EJ, Klinkenberg-Knol EC,et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. J Gastroenterol,1999,94:884-887.
6Wu JC, Sung JJ, Chan FK, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther,2000 ; 14: 427-432.
7Labenz J, Blum AL, Bayerdrffer E, et al. Curing helicobacter pylori infection in patints with duodenal ulcer may provoke reflux esophagitis. Gastroenterology,1997,112:1442-1447.
8Fallone CA,Barkun AN,Friedman G,et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease. Am J Gastroenterol,2000,95: 914-920.
9Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatus hernia and corpus gastritis. Aliment Pharmacol Ther, 2000,14:729-735.
10Tepes B, Kavcic B, Gubina M, et al. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication. Hepatogastroenterology, 1999,46: 1746-1750.
